Immix Biopharma, Inc. (IMMX)

NCM – Real Time Price. Currency in USD

10.66

+0.74 (7.46%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

Cost of goods sold

-365K

-115K

-5K

-2K

Gross Profit

-365K

-115K

-5K

-2K

Operating expenses (excl. COGS)

-27M

-23M

-16M

-8M

Operating Income

-27M

-23M

-16M

-8M

Non-operating income, total

-2M

978K

571K

-497.00

Pretax income

-29M

-22M

-16M

-8M

Equity in earnings

Taxes

-38K

-41K

-26K

-10K

Non-controlling/minority interest

85K

169K

After tax other income/expense

Net income before discontinued operations

-29M

-22M

-15M

-8M

Immix Biopharma, Inc. (IMMX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Immix Biopharma, Inc. (IMMX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Immix Biopharma, Inc. (IMMX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Immix Biopharma, Inc. (IMMX)

Income Statement (Annual)

Income Statement (Annual)